2 March 2017

PDMR Dealing

RNS Number : 3484Y

Verona Pharma PLC

02 March 2017

 

 

Verona Pharma plc

 

PDMR Dealing

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Dr. Jan-Anders Karlsson

2

Reason for the notification


a)


Position/status

 

 

Chief Executive Officer

b)

Initial notification/Amendment

 

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Verona Pharma plc

b)

LEI

 

n/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB00BYW2KH80

b)

Nature of the transaction

 

 

Jan-Anders Karlsson purchased 19,750 Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

149 pence per Ordinary Share

12,000 Ordinary Shares

149 pence per Ordinary Share

7,750 Ordinary Shares

 

d)

Aggregated information

-         Aggregated volume

-         Price

 

 

19,750 Ordinary Shares at 149 pence per Ordinary Share

 

e)

Date of the transaction

12,000 Ordinary Shares on 28 February 2017 and 7,750 Ordinary Shares on 1 March 2017

f)

Place of the transaction

 

 

London Stock Exchange, AIM

 


This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

DSHEANDAEDFXEEF


For further information please contact:

 

Verona Pharma plc
Jan-Anders Karlsson, CEO
Tel: +44 (0)20 3283 4200
info@veronapharma.com

N+1 Singer (Nominated Adviser and UK Broker)
Aubrey Powell / James White
Tel: +44 (0)20 7496 3000

 

 

FTI Consulting
Simon Conway / Stephanie Cuthbert / Natalie Garland-Collins
Tel: +44 (0)20 3727 1000
veronapharma@fticonsulting.com

ICR, Inc. (US Media and Investor enquiries)
James Heins
Tel: +1 203-682-8251
James.Heins@icrinc.com

Stephanie Carrington
Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com


Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us